Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.
Nucleotide Transient Binding For Sequencing Methods
Peter B. VANDER HORN - Encinitas CA, US Cheng-Yao Chen - Carlsbad CA, US Guobin Luo - Oceanside CA, US Michael Previte - Carlsbad CA, US Jamshid Temirov - Germantown TN, US Theo Nikiforov - Carlsbad CA, US Zhaohui Zhou - San Ramon CA, US Hongye Sun - Belmont CA, US Yufang Wang - Foster City CA, US Stefanie Yukiko Nishimura - Mountain View CA, US Hongyi Wang - Pearland TX, US Marian Peris - Belmont CA, US Barnett B. Rosenblum - San Jose CA, US Michael Phelan - Hayward CA, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12Q 1/68 C12N 9/96
US Classification:
435 6, 435188
Abstract:
Provided herein are compositions and systems for use in polymerase-dependent, nucleotide transient-binding methods. The methods are useful for deducing the sequence of a template nucleic acid molecule and single nucleotide polymorphism (SNP) analyses. The methods rely on the fact that the polymerase transient-binding time for a complementary nucleotide is longer compared to that of a non-complementary nucleotide. The labeled nucleotides transiently-binds the polymerase in a template-dependent manner, but does not incorporate. The methods are conducted under any reaction condition that permits transient binding of a complementary or non-complementary nucleotide to a polymerase, and inhibits nucleotide incorporation.
STEPHEN P. HENDRICKS - LOS GATOS CA, US MICHAEL PHELAN - HAYWARD CA, US MARIAN PERIS - BELMONT CA, US CHENG-YAO CHEN - CARLSBAD CA, US DANIEL MAZUR - SAN DIEGO CA, US XINZHAN PENG - CARLSBAD CA, US AMY CASTILLO - HOUSTON TX, US
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.
Cdna Synthesis Using A Reversibly Inactivated Reverse Transcriptase
Roland Nagel - Santa Cruz CA, US Stephen Hendricks - Los Gatos CA, US Jennifer Berkman - San Francisco CA, US Marian Peris - Belmont CA, US Yulei Wang - Foster City CA, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12P 19/34 C12N 9/10
US Classification:
435 915, 435193
Abstract:
The present invention provides compositions and methods for a reverse transcription reaction using a reversibly inactivated reverse transcriptase enzyme. The reversibly inactivated reverse transcriptase enzyme results from a chemical modification which inactivates the reverse transcriptase enzyme. The activity of the reverse transcriptase enzyme is recovered by an incubation of the reaction mixture at elevated temperature prior to, or as part of the reverse transcription reaction. The reverse transcriptase enzyme of the present invention provides for a signficant reduction in non-specific reverse transcription from template nucleic acid molecules because the formulation of the reaction mixture does not support the formation of reverse transcription products prior to activation of the reverse transcriptase.
Stephen P. HENDRICKS - Los Gatos CA, US Michael PHELAN - Hayward CA, US Marian PERIS - Belmont CA, US Cheng-Yao CHEN - Carlsbad CA, US Daniel MAZUR - San Diego CA, US Xinzhan PENG - Carlsbad CA, US Amy CASTILLO - Houston TX, US
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.
Marian PERIS - Belmont CA, US Michael PHELAN - Hayward CA, US Barnett B. ROSENBLUM - San Jose CA, US Stephen P. HENDRICKS - Los Gatos CA, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12N 9/12
US Classification:
435194
Abstract:
Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.
- Carlsbad CA, US Michael Phelan - Millbrae CA, US Marian Peris - San Mateo CA, US Cheng-Yao Chen - San Diego CA, US Daniel Mazur - San Diego CA, US Xinzhan Peng - Carlsbad CA, US Amy Castillo - Houston TX, US
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.
Nucleotide Transient Binding For Sequencing Methods
- Carlsbad CA, US Cheng-Yao CHEN - Eugene OR, US Guobin LUO - Oceanside CA, US Michael PREVITE - Carlsbad CA, US Jamshid TEMIROV - Germantown TN, US Theo NIKIFOROV - Carlsbad CA, US Zhaohui ZHOU - San Ramon CA, US Hongye SUN - Belmont CA, US Yufang WANG - San Carlos CA, US Stefanie Yukiko NISHIMURA - Mountain View CA, US Hongyi WANG - Pearland TX, US Marian PERIS - Dublin CA, US Barnett ROSENBLUM - San Jose CA, US Michael PHELAN - Millbrae CA, US
Provided herein are compositions and systems for use in polymerase-dependent, nucleotide transient-binding methods. The methods are useful for deducing the sequence of a template nucleic acid molecule and single nucleotide polymorphism (SNP) analyses. The methods rely on the fact that the polymerase transient-binding time for a complementary nucleotide is longer compared to that of a non-complementary nucleotide. The labeled nucleotides transiently-binds the polymerase in a template-dependent manner, but does not incorporate. The methods are conducted under any reaction condition that permits transient binding of a complementary or non-complementary nucleotide to a polymerase, and inhibits nucleotide incorporation.
Life Technologies Dec 1, 2005 - Oct 1, 2013
Staff Scientist
Eve Biomedical, Inc. Dec 1, 2005 - Oct 1, 2013
Staff Scientist
Howard Hughes Medical Institute Nov 1, 2001 - Dec 1, 2005
Research Specialist
Pacific Biosciences Nov 1, 2001 - Dec 1, 2005
Senior Scientist
Education:
University of California, Los Angeles Jan 1, 1990 - Dec 31, 1998
University of California, Los Angeles 1991 - 1998
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Philosophy
Skills:
Dna Biotechnology Dna Sequencing Sequencing Genomics Molecular Biology Assay Development Cell Culture Fluorescence Protein Purification Qpcr Purification Laboratory Sds Page Lifesciences Characterization Western Blotting Protein Engineering Protein Expression Biochemistry Enzyme Assays Protein Chemistry Biology Technology Transfer Enzymes Research Pcr Genetics Cell Biology R&D Formulation Protein Characterization
Interests:
Social Services Children Civil Rights and Social Action Education Science and Technology Human Rights Animal Welfare Arts and Culture
Oct 2013 to 2000 Senior Staff ScientistLife Technologies/Applied Biosystems South San Francisco, CA Dec 2005 to Oct 2013 Staff Scientist (7+ years)Howard Hughes Medical Institute Berkeley, CA Nov 2001 to Dec 2005 Research Specialist/Lab managerLerner Research Institute, Cleveland Clinic Cleveland, OH Sep 1998 to Oct 2001 Postdoctoral Fellow
Education:
University of California Los Angeles, CA 1998 PhD in Molecular, Cell and Developmental BiologyUniversity of California Los Angeles, CA Jun 1988 B. S. in Cell and Developmental Biology
Skills:
(1) Protein Engineering (2) Protein Purification (3) qPCR (4) CE sequencing (5) assay developement (Fluorescent)
Youtube
The Only Approved Marian Apparition in the Un...
In 1859, a woman by the name of Adele Brise was visited by a "mysterio...
Duration:
46m 58s
Inside one of the most popular Marian shrines...
On the feast of Our Lady of Fatima, EWTN News Nightly with Lauren Ashb...
Duration:
2m 2s
Marian Movement Messages "To the Priests (and...
For twenty-five years, from 1973-1997, an Italian priest named Father ...
Duration:
1h 25m
Marian Mexicanu i atac fosta soie i refuz s f...
Bomb n showbiz! Scandal cu vorbe grele n familia Mexicanilor! Marian M...
Duration:
15m 24s
A true story. An ANGEL appears in peris
Three kids were praying the holy rosary while grazing their fathers fl...
Duration:
5m 3s
Myriam Fares - Ghmorni
Myriam Fares (Arabic: mryam fris; born 3 May 1983) is a Lebanese[1] ...
Duration:
4m 8s
Myriam Fares - Ghamarni
Duration:
4m 5s
The Life and Tragic Ending of Heather Locklear
The Life and Tragic Ending of Heather Locklear Heather Locklear was bo...